Is this you? Create Your Porfile
Avatar

Neil Gallagher

AstraZeneca

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Neil Gallagher is active.

Explore More

Publication

Featured researches published by Neil Gallagher.

Archive | 2004

Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate

Neil Gallagher; Jon Owen Curwen

Cancer Research | 2005

Pre-clinical and early clinical activity of the highly selective, orally available, dual Src/Abl kinase inhibitor AZD0530

Tim P. Green; Laurent Francois Andre Hennequin; Patrick Ple; Robert J. Jones; Glen Clack; Neil Gallagher

Archive | 2004

Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and a biphosphonate

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Combinaison comprenant un n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamide et un analogue de la lhrh et/ou un bisphosphonate

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Kombination aus n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid und einem biphosphonat Combination of N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4-ä1,3,4-oxadiazol-2-ylüphenyl) pyridine-3-sulfonamide and a bisphosphonate

Neil Gallagher; Jon Owen Curwen

Archive | 2004

KOMBINATION AUS N-(3-METHOXY-5-METHYLPYRAZIN-2- YL)-2-(4-Ä1,3,4-OXADIAZOL-2-YLÜPHENYL)PYRIDIN-3 SULFONAMID UND EINEM BIPHOSPHONAT

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Combinaison a base de n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamide et d'un bisphosphonate

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Combination of N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4-ä1,3,4-oxadiazol-2-ylüphenyl) pyridine-3-sulfonamide and a bisphosphonate

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Kombination aus n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamid und einem lhrh-analogon und/oder einem bisphosphonat

Neil Gallagher; Jon Owen Curwen

Archive | 2004

Combinacion que comprende n-(3-metoxi-5-metilpirazin-2-il)-2-(4-(1,3,4-oxadiazol-2-il)fenil)piridina-3-sulfonamida y un bifosfonato.

Jon Owen Curwen; Neil Gallagher

Explore More

Collaboration

Dive into the Neil Gallagher's collaboration.

Top Co-Authors
Avatar

Jon Owen Curwen

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Andrew Hughes

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

David William Tonge

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Donna Johnstone

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Glen Clack

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Laurent Francois Andre Hennequin

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Patrick Ple

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Robert J. Jones

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Sian Tomiko Taylor

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Tim P. Green

AstraZeneca

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge